168 related articles for article (PubMed ID: 36158148)
1. Soluble suppression of tumorigenesis-2 is a strong predictor of all-cause, cardiovascular and infection-related mortality risk in haemodialysis patients with diabetes mellitus.
Hammer F; Genser B; Dieplinger B; Egger M; Müller T; Drechsler C; März W; Störk S; Wanner C; Krane V
Clin Kidney J; 2022 Oct; 15(10):1915-1923. PubMed ID: 36158148
[TBL] [Abstract][Full Text] [Related]
2. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study.
Pfetsch V; Sanin V; Jaensch A; Dallmeier D; Mons U; Brenner H; Koenig W; Rothenbacher D
Cardiovasc Drugs Ther; 2017 Apr; 31(2):167-177. PubMed ID: 28283847
[TBL] [Abstract][Full Text] [Related]
3. Predicting long-term cardiovascular outcomes of patients with acute myocardial infarction using soluble ST2.
Somuncu MU; Kalayci B; Avci A; Akgun T; Karakurt H; Demir AR; Avci Y; Can M
Horm Mol Biol Clin Investig; 2020 Feb; 41(2):. PubMed ID: 32112700
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus.
Li M; Duan L; Cai Y; Hao B; Chen J; Li H; Liu H
Cardiovasc Diabetol; 2021 Feb; 20(1):49. PubMed ID: 33608010
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis.
Aimo A; Vergaro G; Passino C; Ripoli A; Ky B; Miller WL; Bayes-Genis A; Anand I; Januzzi JL; Emdin M
JACC Heart Fail; 2017 Apr; 5(4):280-286. PubMed ID: 27816512
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients.
Drechsler C; Pilz S; Obermayer-Pietsch B; Verduijn M; Tomaschitz A; Krane V; Espe K; Dekker F; Brandenburg V; März W; Ritz E; Wanner C
Eur Heart J; 2010 Sep; 31(18):2253-61. PubMed ID: 20688781
[TBL] [Abstract][Full Text] [Related]
7. [Soluble Suppression of Tumorogenicity 2 Increases Opportunities for Risk Stratification After Acute Heart Failure Decompensation].
Skvortsov AA; Protasov VN; Narusov OY; Koshkina DE; Nasonova SN; Masenko VP; Tereschenko SN
Kardiologiia; 2017 Jan; (1):48-58. PubMed ID: 28290833
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study.
Kollerits B; Drechsler C; Krane V; Lamina C; März W; Dieplinger H; Ritz E; Wanner C; Kronenberg F;
Nephrol Dial Transplant; 2016 Nov; 31(11):1901-1908. PubMed ID: 26754832
[TBL] [Abstract][Full Text] [Related]
9. Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients.
Winkler K; Wanner C; Drechsler C; Lilienthal J; März W; Krane V;
Eur Heart J; 2008 Sep; 29(17):2092-9. PubMed ID: 18617483
[TBL] [Abstract][Full Text] [Related]
10. Impact of vitamin A on clinical outcomes in haemodialysis patients.
Espe KM; Raila J; Henze A; Krane V; Schweigert FJ; Hocher B; Wanner C; Drechsler C;
Nephrol Dial Transplant; 2011 Dec; 26(12):4054-61. PubMed ID: 21543660
[TBL] [Abstract][Full Text] [Related]
11. The association between soluble suppression of tumorigenicity-2 and long-term prognosis in patients with coronary artery disease: A meta-analysis.
Liu N; Hang T; Gao X; Yang W; Kong W; Lou Q; Yang J
PLoS One; 2020; 15(9):e0238775. PubMed ID: 32886697
[TBL] [Abstract][Full Text] [Related]
12. Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease: results from the Ludwigshafen risk and cardiovascular health study.
Dieplinger B; Egger M; Haltmayer M; Kleber ME; Scharnagl H; Silbernagel G; de Boer RA; Maerz W; Mueller T
Clin Chem; 2014 Mar; 60(3):530-40. PubMed ID: 24401186
[TBL] [Abstract][Full Text] [Related]
13. ST2 may not be a useful predictor for incident cardiovascular events, heart failure and mortality.
Hughes MF; Appelbaum S; Havulinna AS; Jagodzinski A; Zeller T; Kee F; Blankenberg S; Salomaa V;
Heart; 2014 Nov; 100(21):1715-21. PubMed ID: 25080471
[TBL] [Abstract][Full Text] [Related]
14. Hepcidin-25 is related to cardiovascular events in chronic haemodialysis patients.
van der Weerd NC; Grooteman MP; Bots ML; van den Dorpel MA; den Hoedt CH; Mazairac AH; Nubé MJ; Penne EL; Wetzels JF; Wiegerinck ET; Swinkels DW; Blankestijn PJ; Ter Wee PM;
Nephrol Dial Transplant; 2013 Dec; 28(12):3062-71. PubMed ID: 23147161
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein A-IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus--a post hoc analysis of the 4D Study.
Kollerits B; Krane V; Drechsler C; Lamina C; März W; Ritz E; Wanner C; Kronenberg F;
J Intern Med; 2012 Dec; 272(6):592-600. PubMed ID: 22891946
[TBL] [Abstract][Full Text] [Related]
16. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of soluble ST2 in acute coronary syndrome with diabetes.
Jha D; Goenka L; Ramamoorthy T; Sharma M; Dhandapani VE; George M
Eur J Clin Invest; 2018 Sep; 48(9):e12994. PubMed ID: 29992539
[TBL] [Abstract][Full Text] [Related]
18. Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure.
Mueller T; Dieplinger B; Gegenhuber A; Poelz W; Pacher R; Haltmayer M
Clin Chem; 2008 Apr; 54(4):752-6. PubMed ID: 18375488
[TBL] [Abstract][Full Text] [Related]
19. Circulating Soluble ST2 Predicts All-Cause Mortality in Severe Heart Failure Patients with an Implantable Cardioverter Defibrillator.
Hou ZW; Yu HB; Liang YC; Gao Y; Xu GQ; Wu M; Mei Z; Wang ZL; Li ZG; Li YY; Song HX; Li JY; Han YL
Cardiol Res Pract; 2020; 2020():4375651. PubMed ID: 33282418
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Soluble ST2 After Myocardial Infarction: A Community Perspective.
Jenkins WS; Roger VL; Jaffe AS; Weston SA; AbouEzzeddine OF; Jiang R; Manemann SM; Enriquez-Sarano M
Am J Med; 2017 Sep; 130(9):1112.e9-1112.e15. PubMed ID: 28344136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
